n-vinyl-2-pyrrolidinone has been researched along with Papillomavirus Infections in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ali, AA; Cole, G; Donnelly, RF; Dunne, NJ; Kissenpfennig, A; McBride, JW; McCaffrey, J; McCarthy, HO; McCrudden, CM; Robson, T | 1 |
Chalau, VN; Istomin, YP; Lapzevich, TP; Shliakhtsin, SV; Trukhachova, TV | 1 |
2 other study(ies) available for n-vinyl-2-pyrrolidinone and Papillomavirus Infections
Article | Year |
---|---|
DNA vaccination for cervical cancer; a novel technology platform of RALA mediated gene delivery via polymeric microneedles.
Topics: Administration, Cutaneous; Animals; Cancer Vaccines; Cell Line; Cervix Uteri; DNA-Binding Proteins; Female; Gene Transfer Techniques; Human papillomavirus 16; Human papillomavirus 18; Humans; Immunity, Humoral; Mice, Inbred C57BL; Needles; Oligopeptides; Oncogene Proteins, Viral; Papillomavirus Infections; Povidone; Repressor Proteins; Uterine Cervical Neoplasms; Vaccination; Vaccines, DNA | 2017 |
Photodynamic therapy of cervical intraepithelial neoplasia grades II and III with Photolon.
Topics: Adult; Chlorophyllides; Female; Humans; Neoplasm Staging; Papillomavirus Infections; Photochemotherapy; Photosensitizing Agents; Porphyrins; Povidone; Protoporphyrins; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms | 2010 |